Article
Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia
1 Sept 2005
Abstract excerpt
The concept of Waldenstrom macroglobulinemia has evolved from the original description of a clinical syndrome to its more recent designation as a distinct clinicopathologic entity, that is, lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia (LPL/WM), in the World Health Organization (WHO) classification and by the participants of consensus meetings on WM. The diagnosis of LPL/WM, however, remains a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
